Breaking News: Yinuorui has been recognized as the Hubei Province Enterprise Technology Center.

On September 17, 2021, five departments—the Hubei Provincial Development and Reform Commission, the Provincial Department of Science and Technology, the Provincial Department of Finance, Wuhan Customs, and the Hubei Provincial Tax Bureau of the State Administration of Taxation—jointly announced the list of enterprises recognized as Hubei Provincial Enterprise Technology Centers for 2021, and Hubei Enoray Biopharmaceutical Co., Ltd. was among those listed.
 

In accordance with the application requirements for provincial-level enterprise technology centers, our company has been recognized as a Hubei Province Enterprise Technology Center for 2021 (the 27th batch) after going through several stages, including self-application, preliminary review of submitted materials, expert defense and evaluation, and on-site inspection. We are one of the three enterprises from Huanggang City that were approved in 2021.

The successful accreditation as a provincial-level enterprise technology center is the result of YinoRui’s continuous efforts to advance technological innovation, supported and strongly promoted by Hongri Pharmaceutical. It also represents an important milestone in the company’s development of an independent innovation system. Moving forward, under the guidance and support of the Hongri Pharmaceutical Research Institute, we will further intensify our investment in technological innovation, focusing on the research and development of heparin polysaccharide-based drugs, thereby enhancing our enterprise’s capacity for independent innovation and driving its innovative development.